Home > Research Areas > Infection > Influenza
Cat. No. Product name CAS No.
DC11056 Baloxavir marboxil Featured

Baloxavir marboxil is a prodrug of S-033447. S-033447 is a small molecule inhibitor of the cap-dependent endonuclease of influenza A and B viruses.

DC9486 Nucleozin Featured

Nucleozin targets influenza A nucleoprotein (NP), a multifunctional, RNA-binding protein necessary for virus replication.

DCAPI1594 Oseltamivir phosphate Featured

OSELTAMIVIR is an active (orally) inhibitor of the influenze virus neuraminidase and converted to the active acid metabolite in vivo.

DCAPI1121 Peramivir


DCAPI1010 Peramivir Trihydrate Featured

Peramivir, also known as BCX1812 and RWJ 270201, is an antiviral drug for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. Peramivir was approved to treat influenza infection in adults.

DC9815 Pimodivir(VX-787) Featured

Pimodivir(VX-787) is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. 

DC5105 Favipiravir (T-705) Featured

T 705(Favipiravir) is a RNA-directed RNA polymerase NS5B inhibitor.T 705(Favipiravir) is useful for Antiviral agents.

DC8429 Verdinexor (KPT-335) Featured

Verdinexor (KPT-335) is an orally bioavailable, selective XPO1/CRM1 inhibitor.

DCAPI1063 Zanamivir (Relenza) Featured

Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively.

Page 1 / Total 1 FirstPrevNextLastGoto